Anvisa anuncia critérios para a liberação emergencial da vacina contra a covid-19
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
A Anvisa deverá liberar o uso emergencial de uma vacina contra a Covid-19 sem a necessidade de registro. A medida será tomada seguindo critérios específicos, enquanto laboratórios continuam as pesquisas.
show moreInformation
Author | RECORD |
Organization | RecordTV (Brazil) |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company